Bone marrow concentrated cell transplantation: rationale for its use in the treatment of human osteochondral lesions.

Journal of biological regulators and homeostatic agents

Volumn 27, Issue 1, 2013, Pages 165-175

  Cavallo, C ^a   Desando, G ^b   Cattini, L ^b   Cavallo, M ^b   Buda, R ^b   Giannini, S ^b   Facchini, A ^b   Grigolo, B ^b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; ALCIAN BLUE; ALIZARIN; ALKALINE PHOSPHATASE; ANTHRAQUINONE DERIVATIVE; COLLAGEN TYPE 2; MESSENGER RNA; TRANSCRIPTION FACTOR SOX9;

ADULT; ARTICLE; BONE DEVELOPMENT; BONE DISEASE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHONDROGENESIS; CLONOGENIC ASSAY; CYTOLOGY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STAINING;

ADULT; AGGRECANS; ALCIAN BLUE; ALKALINE PHOSPHATASE; ANTHRAQUINONES; BONE DISEASES; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHONDROGENESIS; COLLAGEN TYPE II; COLONY-FORMING UNITS ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; OSTEOGENESIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOX9 TRANSCRIPTION FACTOR; STAINING AND LABELING;

EID: 84878794697     PISSN: 0393974X     EISSN: None     Source Type: None    
DOI: None     Document Type: Article

References (0)